Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 218 (2) , 163-170
- https://doi.org/10.1016/j.canlet.2004.06.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) miceBiochemical and Biophysical Research Communications, 2003
- Cyclooxygenase-2 as a Potential Target in the Prevention and Treatment of Genitourinary Tumors: A ReviewJournal of Urology, 2003
- The therapeutic potential of NO‐NSAIDsFundamental & Clinical Pharmacology, 2003
- Cyclooxygenase‐2 promotes prostate cancer progressionThe Prostate, 2002
- Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent EffectThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Nitric oxide-induced apoptosis in tumor cellsPublished by Elsevier ,2001
- Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinomaLife Sciences, 1998
- The multifaceted roles of nitric oxide in cancerCarcinogenesis: Integrative Cancer Research, 1998
- Novel nonsterodial anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the ratPublished by Elsevier ,1994
- Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomachLife Sciences, 1989